Polyunsaturated Fatty Acids: Biochemical, Nutritional and Epigenetic Properties

Journal of the American College of Nutrition

Volumn 23, Issue 4, 2004, Pages 281-302

  Benatti, Paola ^a   Nicolai, Raffaella ^a   Calvani, Menotti ^a   Peluso, Gianfranco ^b  

^a Sigma Tau SpA   (Italy)

^b Natl Cancer Inst Via V   (Italy)

Author keywords

Carnitine; Chronic diseases; Eicosanoid metabolism; Gene expression; Nutrition; Polyunsaturated fatty acids

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; BRADYKININ; CARNITINE; CELECOXIB; CYCLOOXYGENASE 2; CYTOKINE; DEXAMETHASONE; DICLOFENAC; HEPATOCYTE NUCLEAR FACTOR 4; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LEUKOTRIENE B4; LEUKOTRIENE B5; LINOLEIC ACID; LINOLENIC ACID; LIPOXYGENASE; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID; PROSTACYCLIN; PROSTAGLANDIN E; PYRIDOXINE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; THROMBOXANE; THYROID HORMONE RECEPTOR; TROGLITAZONE;

ALCOHOL CONSUMPTION; ANTIARRHYTHMIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; BONE GROWTH; BONE REMODELING; BRAIN FUNCTION; CACHEXIA; CANCER; CELL PROLIFERATION; CHEMISTRY; CHRONIC DISEASE; DIABETES MELLITUS; EPIGENETICS; EXERCISE; FATTY ACID METABOLISM; FETUS DEVELOPMENT; GENE EXPRESSION; HUMAN; HYPERLIPIDEMIA; ICOSANOID METABOLISM; INSULIN RESISTANCE; LIPID DIET; MOOD; NONHUMAN; NUTRITION; NUTRITIONAL REQUIREMENT; PREGNANCY; PSORIASIS; RESTENOSIS; REVIEW; SIGNAL TRANSDUCTION; STRESS; THROMBOSIS; ULCERATIVE COLITIS; VITAMIN DEFICIENCY;

ANIMALS; CHRONIC DISEASE; DIETARY FATS; DIETARY FATS, UNSATURATED; FATTY ACIDS, UNSATURATED; GENE EXPRESSION REGULATION; HUMANS; NUTRITIONAL STATUS; TRANSCRIPTION, GENETIC;

EID: 4143147532     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2004.10719371     Document Type: Article

References (166)

1. Simopoulos AP: Executive Summary. In Galli C, Simopoulos AP (eds): “Dietary Omega-3 and Omega-6 Fatty Acids: Biological effects and Nutritional Essentiality. Series A: Life Sciences.” New York: Plenum-Press, Vol 171, pp 391-402, 1989.
2. Simopoulos AP, Kifer RR, Martin RE (eds): “Health Effects of Polyunsaturated Fatty Acids in Seafoods.” Orlando, FL: Academic Press, 1986.
3. Adam O: Linoleic and linolenic acids intake. In Galli C, Simopoulos AP (eds): “Dietary Omega-3 and Omega-6 Fatty Acids: Biological effects and Nutritional Essentiality. Series A: Life Sciences,” vol 171. New York: Plenum-Press, pp 391-402, 1989.
4. Phinney SD, Odin RS, Johnson SB, Holman RT: Reduced arachidonate in serum phospholipids and cholesteryl esters associated with vegetarian diet in humans. Am J Clin Nutr 51:385-392, 1990.
5. Raper NR, Cronin FJ, Exler J: Omega-3 fatty acid content of the US food supply. J Am Coll Nutr 11:304-308, 1992.
6. FAO/WHO: Fats and oils in human nutrition report of a joint expert consultation. Food and Agriculture Organization of the United Nations and the World Health Organization. FAO. Food Nutr Pap 57:1-147, 1994.
7. British Nutrition Foundation. Task Force on Unsaturated Fatty Acids. London: Chapman and Hall, 1992.
8. Kris-Etherton P, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V, Hargrove RL, Zhao G, Etherton TD: Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 71:179-188, 2000.
9. Sugano AM, Hirata F: Polyunsaturated fatty acids in food chain in Japan. Am J Clin Nutr 71(Suppl):S189-S196, 2000.
10. Hughes CL, Dhiman TR: Dietary compounds in relation to dietary diversity and human health. J Med Food 5:51-68, 2002.
11. Holman RT: The slow discovery of the importance of omega 3 essential fatty acids in human health. J Nutr 128:427S-433S, 1998.
12. Sprecher H, Luthria DL, Mohammed BS, Baykousheva SP: Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids. J Lipid Res 36:2471-2477, 1995.
13. Sprecher H, Chen Q, Yin FQ: Regulation of the biosynthesis of 22:5n-6 and 22:6n-3: a complex intracellular process. Lipids 34:S153-S156, 1999.
14. Infante JP, Huszagh VA: On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosa-hexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders. Mol Cell Biochem 168:101-115, 1997.
15. Infante JP, Huszagh VA: Analysis of the putative role of 24-carbon polyunsaturated fatty acids in the biosynthesis of docosa-pentaenoic (22:5n6) and docosahexaenoic (22:6n-3) acids. FEBS Lett 431:1-6, 1998.
16. Mohrhauer H, Christiansen K, Gan MV, Deubig M, Holman RT: Chain elongation of linoleic acid and its inhibition by other fatty acids in vitro. J Biol Chem 242:4507-4517, 1967.
17. Jump DB, Clarke SD: Regulation of gene expression by dietary fat. Annu Rev Nutr 19:63-90, 1999.
18. Lauritzen L, Hansen HS, Jorgensen MH, Michaelsen KF: The essentiality of long-chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 40:1 2001.
19. James MJ, Gibson RA and Cleland LG: Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71:343S-348S, 2000.
20. Petersen C, Baumann M, Petersen S: New targets for the modulation of radiation response—selective inhibition of the enzyme cyclooxygenase 2. Curr Med Chem Anti-Canc Agents 3:354359, 2003.
21. Corey EJ, Shih C, Cashman JR: Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci USA 80:3581-3584, 1983.
22. Smith WL, Garaviti M, and DeWitt DL: Prostaglandin Endoperoxide H Synthase (Cyclooxygenase)-1 and -2. J Biol Chem 271: 33157-33160, 1996.
23. Porter NA, Caldwell SE, Mills KA: Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30:277-290, 1995.
24. Capdevila JH, Falck JR, Harris RC: Cytochrome P450 and ara-chidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J Lipid Res 41:163-181, 2000.
25. Serhan CN and Oliw E: Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J Clin Invest 107:1481-1489, 2001.
26. Waber PC, Fischer S, von Schacky C: Dietary omega-3 polyunsaturated fatty acids and eicosanoid formation in man. In Simo-poulos AP, Kifer RR, Martin RE (eds): “Health Effects of Polyunsaturated Fatty Acids in Seafoods.” Orlando, FL: Academic Press, pp 49-60, 1986.
27. Lewis RA, Lee TH, Austen KF: Effects ofomega-3 fatty acids on the generation of products of the 5-lipooxygenase pathway. In Simopoulos AP, Kifer RR, Martin RE (eds): “Health Effects of Polyunsaturated Fatty Acids in Seafoods.” Orlando, FL: Academic Press, pp 227-238, 1986.
28. Jump DB, Clarke SD, Thelen A, Liimatta M, Ren B, Badin M Dietary polyunsaturated fatty acid regulation of gene transcription. Prog Lipid Res 35:227-241, 1996.
29. Takada R, Saitoh M, Mori T: Dietary gamma-linolenic acid enriched oil reduces body fat content and induces liver enzyme activities relating to fatty acid beta-oxidation in rats. J Nutr 124:469-474, 1994.
30. Power GW, Newsholme EA: Dietary fatty acids influence the activity and metabolic control of mitochondrial carnitine palmitoyltransferase I in rat heart and skeletal muscle. J Nutr 127: 2142-2150, 1997.
31. Miller CC, Ziboh VA: Induction of epidermal hyperproliferation by topical n-3 polyunsaturated fatty acids on guinea pig skin linked to decreased levels of 13-hydroxyoctadecadienoic acid (13-HODE). J Invest Dermatol 94:353-358, 1990.
32. Kidweel WR: Fatty acid growth requirements of normal and neoplastic mammary epithelium. Prog Clin Biol Res 222:699707, 1986.
33. Lambe KG, Tugwood JD: A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogene-sis, including thiazolidinedione drugs. Eur J Biochem 239:83-98, 1996.
34. Jump DB, Clarke SD, MacDougald OA, Thelen A: Polyunsaturated fatty acids inhibit S14 gene transcription in rat liver and cultured hepatocytes. Proc Natl Acad Sci USA 90:8454-8458, 1993.
35. Jump DB, Clarke SD, Thelen AT, Liimatta M: Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids. J Lipid Res 35:1076-1084, 1994.
36. Clarke SD, Jump DB: Fatty acid regulation of gene expression; a unique role for polyunsaturated fats. In Berdanier CD, Hargrove JL (eds): “Nutrition and Gene Expression.” Boca Raton, FL: CRC Reviews, pp 227-245, 1992.
37. Desvergne B, Wahli, W: Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20, 649-688, 1999.
38. Mascaro C, Acosta E, Ortiz JA, Marrero PF, Hegardt FG, Haro D: Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J Biol Chem 273:8560-8563, 1998.
39. Rodriguez JC, Gil-Gomez B, Hegradt FG, Haro D: Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J Biol Chem 269:18767-18772, 1994.
40. Varanasi U, Chu R, Huang Q, Castellon R, Yeldandi AV, Reddy JK: Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl CoA oxidase gene. J Biol Chem 271:2147-2155, 1996.
41. Aubert J, Champigny O, Saint-Marc P, Negrel R, Collins S, Ricquier D, Ailhaud G: Upregulation of UCP-2 gene expression by PPAR agonists in preadipose and adipose cells. Biochem Biophys Res Commun 238:606-611, 1997.
42. Ye JM, Doyle PJ, Iglesias MA, Watson DG, Cooney GJ, Kraegen EW: W. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Diabetes 50:411-417, 2001.
43. Guerre-Millo, M, Gervois P, Raspe E, Madsen E, Poulain P, Derudas B, Gerbert JM, Winegar DA, Willson TM, Fruchart JC, Berge RK, Staels B: Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem 275:16638-16642, 2000.
44. Storlien L, Hulbert AJ, and Else PL: Polyunsaturated fatty acids, membrane function and metabolic diseases such as diabetes and obesity. Curr. Opin. Clin. Nutr. Metab. Care 1:559-563, 1998.
45. Duplus E, Glorian M, and Forest C: Fatty acid regulation of gene transcription. J Biol Chem 275:30749-30752, 2000.
46. de Urquiza AM, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, Perlmann T: Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290:2140-2144, 2000.
47. Hertz R, Magenheim J, Berman I, Bar-Tana J: Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 392:512-516, 1997.
48. Ou J, Tu H, Shan B, Luk A, DeBose-Boyd RA, Bashmakov Y, Goldstein JL, Brown MS: Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci USA 98:6027-6032, 2000.
49. Hannah VC, Ou J, Luong A, Goldstein JL, Brown MS: Unsaturated Fatty Acids Down-regulate SREBP Isoforms 1a and 1c by Two Mechanisms in HEK-293 Cells. J Biol Chem 276:4365-4372, 2001.
50. DeBose-Boyd RA, Ou J, Goldstein JL, Brown MS: Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands. Pro Natl. Acad Sci USA 98:1477-1482, 2001.
51. Osborne TF: Sterol Regulatory Element-binding Proteins (SREBPs): Key Regulators of Nutritional Homeostasis and Insulin Action. J Biol Chem 275:32379-32382, 2000.
52. Ren B, Thelen AP, Peters JM, Gonzalez FJ, Jump DB: Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alfa. J Biol Chem 272:26827-26832, 1997.
53. Xu J, Nakamura MT, Cho HP, Clarke S: Sterol Regulatory Element Binding Protein-1 Expression Is Suppressed by Dietary Polyunsaturated Fatty Acids. J Biol Chem 274:23577-23583, 1999.
54. Kim HJ, Takahashi M, Ezaki O: Fish Oil Feeding Decreases Mature Sterol Regulatory Element-binding Protein 1 (SREBP-1) by Down-regulation of SREBP-1c mRNA in Mouse Liver. J Biol Chem 274:25892-25898, 1999.
55. Mater MK, Thelen AP, Pan DA, Jump DB: Sterol Response Element-binding Protein 1c (SREBP1c) Is Involved in the Polyunsaturated Fatty Acid Suppression of Hepatic S14 Gene Transcription. J Biol Chem 274:32725-32732, 1999.
56. Hertz R, Magenheim J, Berman I, Bar-Tana J: Fatty acid-CoA esters are ligands of hepatic nuclear factor-4. Nature 392:512-516, 1998.
57. Liimatta M, Towle HC, Clarke SD, Jump DB: Dietary polyunsaturated fatty acids interfere with the insulin/glucose activation of L-type pyruvate kinase gene transcription. Mol Endocrinology 8:1147-1153, 1999.
58. Van der Klis FR, Schmidt ED, van Beeren HC, Wiersinga WM: Competitive inhibition ofT3 binding to alpha 1 and beta 1 thyroid hormone receptors by fatty acids. Biochem Biophys Res Commun. 179:1011-1016, 1991.
59. Juge-Aubry CE, Gorla-Bajszczak A, Pernin A, Lemberger T, Wahli W, Burger AG, Meier CA: Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat. J Biol Chem. 270:1811718122, 1995.
60. Brenner RR: Nutritional and hormonal factors influencing desaturation of essential fatty acids. Prog Lipid Res 20:41-47, 1981.
61. Helge JW, Wu BJ, Willer M: Training affects muscle phospholipid fatty acid composition in humans. J Appl Physiol 90:670-677, 2001.
62. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV: The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 328:238-244, 1993.
63. Storlien LH, Baur LA, Kriketos Ad, Pan DA, Cooney GJ, Jenkins AB, Calvert GD, Campbell LV: Dietary fats and insulin action. Diabetologia 39:621-631, 1996.
64. Vessby B, Tengblad S, and Lithell H: Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 37:1044-1050, 1994.
65. Eck MG, Wynn JO, Carter WJ, Faas FH: Fatty acid desaturation in experimental diabetes. Diabetes 28:479-485, 1979.
66. Mimouni V, Poisson JP: Altered desaturase activities and fatty acid composition in liver microsomes of spontaneously diabetic Wistar BB rat. Biochim Biophys Acta 1123:296-302, 1992.
67. Bassi A, Avogaro A, Crepaldi C, Zambon S, Marin R, Macdonald I, Manzato E: Short-term diabetic ketosis alters n-6 polyunsaturated fatty acid content in plasma phospholipids. J Clin Endocrinol Metab 81:1650-1653, 1992.
68. Ginsberg BH, Jabour J, and Spector AA: Effects of alterations in membrane lipid unsaturation on the properties of the insulin receptor of Ehrlich ascites cells. Biochim Biophys Acta 690:157-1982.
69. Grunfeld C, Baird KL, and Kahn CR: Maintenance of 3T3-L1 cells in culture media containing saturated fatty acids decreases insulin binding and insulin action. Biochem Biophys Res Commun 103:219-226, 1981.
70. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW: Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40:280-289, 1991.
71. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV: The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 328:238-244, 1993.
72. Clore JN, Li J, Gill R, Gupta S, Spencer R, Azzam A, Zuelzer W, Rizzo WB, Blackard WG: Skeletal muscle phosphatidylcholine fatty acids and insulin sensitivity in normal humans. Am J Physiol Endocrinol Metab 275:E665-E670, 1998.
73. Pan DA, Lillioja S, Milner MR, Kriketos AD, Baur LA, Bogardus C, Storlien LH: Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest 96:2802-2808, 1995.
74. Ayre KJ, Hulbert AJ: Dietary fatty acid profile influences the composition of skeletal muscle phospholipids in rats. J Nutr 126:653-662, 1996.
75. Baur LA, O’Connor J, Pan DA, Kriketos AD, Storlien LH: The fatty acid composition of skeletal muscle membrane phospholipid: its relationship with the type of feeding and plasma glucose levels in young children. Metabolism 47:106-112, 1998.
76. Vessby B, Gustafsson IB, Tengblad S, Boberg M, Andersson A: Desaturation and elongation of fatty acids and insulin action. Annals of the New York Academy of Sciences 967:183-195, 2002.
77. Lillioja S, Young AA, Culter CL, Ivy JL, Abbott WG, Zawadzki JK, Yki-Jarvinen H, Christin L, Secomb TW, Bogardus C: Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80:415-424, 1987.
78. Saltin B, Henriksson J, Nygaard E, Andersen P, Jansson E: Fiber types and metabolic potentials of skeletal muscles in sedentary man and endurance runners. Ann NY Acad Sci 301:3-29, 1977.
79. Kriketos AD, Pan DA, Sutton JR, Hoh JF, Baur LA, Cooney GJ, Jenkins AB, Storlien LH: Relationships between muscle membrane lipids, fiber type, and enzyme activities in sedentary and exercised rats. Am J Physiol Regulatory Integrative Comp Physiol 269:R1154-R1162, 1995.
80. Bordoni A, Hrelia S, Lorenzini A, Bergami R, Cabrini L, Biagi PL, Tolomelli B: Dual influence of aging and vitamin B6 deficiency on delta-6-desaturation of essential fatty acids in rat liver microsomes. Prostaglandins Leukot Essent Fatty Acids 58:417-420, 1998.
81. Despret S, Dinh L, Clement M, Bourre JM: Alteration of delta-6 desaturase by vitamin E in rat brain and liver. Neurosci Lett 145:19-22, 1992.
82. Narce M, Poisson JP, Bellenger J, Bellenger S: Effect of ethanol on polyunsaturated fatty acid biosynthesis in hepatocytes from spontaneously hypertensive rats. Alcohol Clin Exp Res 25:1231-1237, 2001.
83. Maxwell WJ, Keating JJ, Hogan FP, Kennedy NP, Keeling PW: Prostaglandin E2 and leukotriene B4 synthesis by peripheral leucocytes in alcoholics. Gut 30:1270-1274, 1989.
84. Gudbjarnason S: Dynamics of n-3 and n-6 fatty acids in phospholipids of heart muscle. J Int Med 225 (Suppl 1):117-128, 1989.
85. Wahl HG, Kausch C, Machicao F, Rett K, Stumvoll M, Haring HU: Troglitazone Downregulates delta-6 Desaturase Gene Expression in Human Skeletal Muscle Cell Cultures. Diabetes 51: 1060-1065, 2002.
86. Hope A, Fitzpatrick-Wong S: Dietary long-chain polyunsaturated fatty acids minimize dexamethasone-induced reductions in ara-chidonic acid status but not bone mineral content in piglets. Pediatric Research 51:282-289, 2002.
87. Kris-Etherton P, Daniels SR, Eckel RH, Engler M, Howard BV, Krauss RM, Lichtenstein AH, Sacks F, St Jeor S, Stampfer M, Eckel RH, Grundy SM, Appel LJ, Byers T, Campos H, Cooney G, Denke MA, Howard BV, Kennedy E, Krauss RM, KrisEtherton P, Lichtenstein AH, Marckmann P, Pearson TA, Riccardi G, Rudel LL, Rudrum M, Sacks F, Stein DT, Tracy RP, Ursin V, Vogel RA, Zock PL, Bazzarre TL, Clark J: Summary of the scientific conference on dietary fatty acids and cardiovascular health. Circulation 103:1034-1039, 2001.
88. Demaison L, Moreau D: Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action. Cell Mol Life Sci 5:463-477, 2002.
89. Charnock JS: Antiarrhythmic effects of fish oils. In: Simopoulos AP, Kifer RR, Martin RE, Barlow SM (eds): “Health Effects of Omega-3 Polyunsaturated Fatty Acids in Seafoods,” vol. 66. Basel: Karger, pp 278-291, 1991.
90. Reibel DK, Holahan MA, Hock CE: Effects of dietary fish oil on cardiac responsiveness to adrenoceptor stimulation. Am J Physiol 254:H494-H499, 1988.
91. Christensen JH, Skou HA, Fog L, Hansen V, Vesterlund T, Dyerberg J, Toft E, Schmidt EB: Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred to coronary angiography. Circulation 103:651-657, 2001.
92. Bigger JT, El-Sherif T: Polyunsaturated fatty acids and cardiovascular events. A fish tale. Circulation 103:623-625, 2001.
93. Kang JX, Leaf A: Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids. Am J Clin Nutr 71:202-207, 2000.
94. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346:1113-1118, 2002.
95. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bovbjerg V, Arbogast P, Smith H, Kushi LH: Dietary intake and cell membrane levels of long-chain omega-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274:1363-1367, 1995.
96. Albert CM, Hennekens CH, O’Donnell CJ, Ajani UA, Carey VJ, Willett WC, Ruskin JN, Manson JE: Fish consumption and risk of sudden cardiac death. JAMA 279:23-28, 1998.
97. De Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Heart Study. Circulation 99:779-785, 1999.
98. Singh RB, Rastoqi SS, Verma R, Laxmi B, Singh R, Ghosh S, Niaz MA: Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. Br Med J 304:1015-1019, 1992.
99. Burr ML, Fehily AM, Gilbert JF: Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction. Diet And Reinfarction Trial (DART). Lancet 2:757-761, 1989.
100. GISSI Investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione TRIAL: Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 354: 447-455, 1999.
101. Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR: Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 312:1210-1216, 1985.
102. Nestel PJ: Fish oil attenuates the cholesterol-induced rise in lipoprotein cholesterol. Am J Clin Nutr 43:752-757, 1986.
103. Nestel PJ, Connor WE, Reardon MR, Connor S, Wong S, Boston R: Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 74:72-89, 1984.
104. Simopoulos AP: Fatty acids. In Goldberg (ed): “Functional foods”. New York, Chapman & Hall, pp 355-391, 1994.
105. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, Gallagher PJ, Calder PC, Grimble RF: Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet 361:477-85, 2003.
106. Eritsland J, Arnesen H, Gronseth K, Fjeld NB, Abdelnoor M: Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 77:31-36, 1996.
107. Bairati I, Roy L, Meyer F: Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 85:950-956, 1992.
108. Appel LJ, Miller ER, III, Seidler AJ, Whelton PK: Does supplementation of diet with “fish oil” reduce blood pressure? A metaanalysis of controlled clinical trials. Arch Intern Med 153:14291438, 1993.
109. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV: The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 328:238-244, 1993.
110. Simopoulos AP: Is insulin resistance influenced by dietary linoleic acid andtrans fatty acids? Free Radic Biol Med 17:367-372, 1994.
111. Yam D, Eliraz A, Berry EM: Diet and disease: the Israeli paradox: possible dangers of a high omega-6 polyunsaturated fatty acid diet. Isr J Med Sci 32:1134-1143, 1996.
112. Simopoulos AP: Fatty acid composition of skeletal muscle membrane phospholipids, insulin resistance and obesity. Nutr Today 2:12-16, 1994.
113. Baur LA, O’Connor J, Pan DA, Storlien LH: Relationships between maternal risk of insulin resistance and the child’s muscle membrane fatty acid composition. Diabetes 48:112-116, 1999.
114. Harris WS: Do omega-3 fatty acids worsen glycemic control in NIDDM? ISSFAL Newsletter 3:6-9, 1996.
115. Connor WE, Prince MJ, Ullmann D, Riddle M, Hatcher L, Smith FE, Wilson D: The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control. Ann N Y Acad Sci 683:337-340, 1993.
116. Rojo-Martinez G, Soriguer FJ, Gonzalez-Romero S, Tinahones F, Moreno F, de Adana SR, Garriga MJ, Esteva I, Garcia-Arnes J, Gomez-Zumaquero JM, Garcia-Almeida JM: Serum leptin and habitual fatty acid dietary intake in patients with type 1 diabetes mellitus. Eur J Endocrinol 142:263-268, 2000.
117. Reseland JE, Haugen F, Hollung K, Solvoll K, Halvorsen B, Brude IR, Nenseter MS, Christiansen EN, Drevon CA: Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 42:743-750, 2001.
118. Shapiro AC, Wu D, Meydani SN: Eicosanoids derived from arachidonic and eicosapentaenoic acids inhibit T cell proliferative response. Prostaglandins 45:229-240, 1993.
119. Meydani SN, Dinarello CA: Influence of dietary fatty acids on cytokine production and its clinical implications. Nutr Clin Pract 8:65-72, 1993.
120. Wander RC, Hall JA, Gradin JL, Du SH, Jewell DE: The ratio of (n-6) to (n-39 fatty acids influences immune system function, eicosanoid metabolism, lipid peroxidation and vitamin E status in aged dogs. J Nutr 127:1198-1205, 1997.
121. Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL, Caterson B: n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem 275:721724, 2000
122. Watkins BA: Regulatory effects ofpolyunsaturates on bone modeling and cartilage function. World Rev Nutr Dietetics 83:38-51, 1998.
123. Watkins BA, Seifert MF, Allen KG: Importance of dietary fat in modulating PGE2 responses and influence of vitamin E on bone morphometry. World Rev Nutr Dietetics 82:250-259, 1997.
124. Watkins BA, Seifert MF: Conjugated linoleic acid and bone biology. J Am Coll Nutr 19:478S-486S, 2000.
125. Rawlinson SC, Mohan S, Baylink DJ, Lanyon LE: Exogenous prostacyclin, but not prostaglandin E2, produces similar responses in both G6PD activity and RNA production as mechanical loading, and increases IGF-II release, in adult cancellous bone in culture. Calcif Tissue Int 53:324-329, 1993.
126. Collins DA, Chambers TJ: Prostaglandin E2 promotes osteoclast formation in murine hematopoietic cultures through an action on hematopoietic cells. J Bone Miner Res 7:555-561, 1992.
127. Tashjian AH, Voelkel EF, Lazzaro M, Goad D, Bosma T, Levine L: Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. Endocrinology 120:2029-2036, 1987.
128. Hurley MM, Lee SK, Raisz LG, Bernecker P, Lorenzo J: Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures. Bone 22:309-316, 1998.
129. Plotquin D, Dekel S, Katz S, Danon A: Prostaglandin release by normal and osteomyelitic human bones. Prostaglandins Leukot Essent Fatty Acids 43:13-15, 1991.
130. Broadhurst CL, Winther M: Evening primrose oil: pharmacological and clinical applications. In Mazza JG, Ooma BD (eds): “Functional Foods: Herbs, Botanicals and Teas.” Lancaster, PA: Technomic Publishing, pp 213-264, 2000.
131. Watkins B, Li Y, Allen KG, Hoffmann WE, Seifert MF: Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J Nutr 130:2274-2284, 2000.
132. Watkins BA, Shen CL, Allen K, Seifert MF: Dietary (n-3) and (n-6) polyunsaturates and acetylsalicylic acid alter ex vivo PGE2 biosynthesis, tissue IGF-I levels, and bone morphometry in chicks. J Bone Miner Res 11:1321-1332, 1996.
133. Xu H, Watkins BA, Adkisson HD: Dietary lipids modify the fatty acid composition of cartilage, isolated chondrocytes and matrix vesicles. Lipids 29:619-625, 1994.
134. Atkinson TG, Barker HJ, Meckling-Gill KA: Incorporation of long-chain n-3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post-weanling Fischer 344 rats. Lipids 32:293-302, 1997.
135. Kokkinos PP, Shaye R, Alam BS, Alam SQ: Dietary lipids, prostaglandin E2 levels, and tooth movement in alveolar bone of rats. CalcifTissue Int 53:333-337, 1993.
136. Alam SQ, Kokkinos PP, Alam BS: Fatty acid composition and arachidonic acid concentrations in alveolar bone of rats fed diets with different lipids. Calcif Tissue Int 53:330-332, 1993.
137. Sakaguchi K, Morita I, Murota S: Eicosapentanoic acid inhibits bone loss due to ovariectomy in rats. Prostaglandins Leukot Essent Fatty Acids 50:81-84, 1994.
138. Claassen N, Coetzer H, Steinmann CM, Kruger MC: The effect of different n-6/n-3 essential fatty acid ratios on calcium balance and bone in rats. Prostaglandins Leukot Essent Fatty Acids 53:13-19, 1995.
139. Schlemmer CK, Coetzer H, Claassen N, Kruger MC: Oestrogen and essential fatty acid supplementation corrects bone loss due to ovariectomy in the female Sprague Dawley rat. Prostaglandins Leukot Essent Fatty Acids 61:381-390, 1999.
140. Kruger MC, Coetzer H, de Winter R, Gericke G, van Papendorp DH: Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano) 10:385394, 1998.
141. Terano T: Effect of omega 3 polyunsaturated fatty acid ingestion on bone metabolism and osteoporosis. World Rev Nutr Diet 88:141-147, 2001.
142. Michelson D, Stratakis C, Hill L, Reynolds J, Galliven E, Chrousos G, Gold P: Bone mineral density in women with depression. New Engl J Med 335:1176-1181, 1996.
143. Horrobin DF, Bennet CN: Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Prostaglandins Leukot Essent Fatty Acids 60:217-234, 1999.
144. Broadhurst CL, Cunnane SC, Crawford MA: Rift Valley lake fish and shellfish provided brain-specific nutrition for early Homo. Br J Nutr 79:3-21, 1998.
145. Innis SM: Essential fatty acids in growth and development. Prog Lipid Res 30:39-103, 1991.
146. Uauy R, Peirano P, Hoffman D, Mena P, Birch D, Birch E: Role of essential fatty acids in the function of the developing nervous system. Lipids 31:S167-S176, 1996.
147. Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR, Burgess JR: Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 62:761-768, 1995.
148. Cheruku SR, Montgomery-Downs HE, Farkas SL, Thoman EB, Lammi-Keefe CJ: Higher maternal plasma docosahexaenoic acid during pregnancy is associated with more mature neonatal sleepstate patterning. Am J Clin Nutr 76:608-613, 2002.
149. Barker DJP: Mothers, babies and disease in later life. London: BMJ Books, 1994.
150. Foreman-van Drongelen MM, Al MD, van Houwelingen AC, Blanco CE, Hornstra G: Comparison between the essential fatty acid status of preterm and full-term infants, measured in umbilical vessels. Early Hum Dev 42:241-251, 1995.
151. Foreman-van Drongelen MMHP, van Houwelingen AC, Kester AD, de Jong AE, Blanco CE, Hasasrt TH, Hornstra G: Longchain polyene status of preterm infants with regard to the fatty acid composition of their diet: comparison between absolute and relative fatty acid levels in plasma and erythrocyte phospholipids. Br J Nutr 73:405-422, 1995.
152. Foreman-van Drongelen MM, Houwelingen AC, Kester AD, de Jong AE, Blanco CE, Hasaart TH, Hornstra G: Influence of feeding artificial-formula milks containing docosahexaenoic and arachidonic acids on the postnatal long-chain polyunsaturated fatty acid status ofhealthy preterm infants. Br J Nutr 76:649-667,1996.
153. van Houwelingen AC, Foreman-van Drongelen MMHP, Nicolini U, Nicolaides KH, Al MD, Kester AD, Hornstra G: Essential fatty acid status of fetal phospholipids: similar to postnatal values obtained at comparable gestational ages. Early Hum Dev 46:141 1996.
154. Foreman-van Drongelen MMHP, van Houwelingen AC, Kester ADM, Hasaart TH, Blanco CE, Hornstra G: Long-chain polyunsaturated fatty acids in preterm infants: status at birth and its influence on postnatal life. J Pediatr 126:611-618, 1995.
155. Koletzko B, Braun M: Arachidonic acid and early human growth: is there a relation? Ann Nutr Metab 35:128-131, 1991.
156. Carlson SE, Werkman SH, Peeples JM, Cooke RJ, Tolley EA: Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci USA 90:1073-1077, 1993.
157. Hamilton MT, Areiqat E, Hamilton DG, Bey L: Plasma triglyceride metabolism in humans and rats during aging and physical inactivity. Int J Sport Nutr Exerc Metab S97-S104, 2001.
158. Chapman C, Morgan LM, Murphy MC: Maternal and early dietary fatty acid intake: changes in lipid metabolism and liver enzymes in adult rats. J Nutr 130:146-151, 2000.
159. Al MDM, van Houwelingen AC, Hornstra G: Relation between birth order and the maternal and neonatal docosahexaenoic acid status. Eur J Clin Nutr 51:548-553, 1997.
160. Lucas A, Morley R, Cole TJ, Lister G, Leeson-Payne C: Breast milk and subsequent intelligence quotient in children born preterm. Lancet 339:261-264, 1992.
161. Rodgers B: Feeding in infancy and later ability and attainment: a longitudinal study. Dev Med Child Neurol 20:421-442, 1978.
162. Gale CR, Martyn CN: Breast feeding, dummy use and intelligence. Lancet 347:1072-1075, 1996.
163. Emken EA, Adlof RO, Gulley RM: Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta 1213:277-288, 1994.
164. Hamilton LC, Mitchell JA, Tomlinson AM, Warner TD: Synergy between cyclo-oxygenase-2 induction and arachidonic acid supply in vivo: consequences for nonsteroidal antiinflammatory drug efficacy. FASEB 13:245-251, 1999.
165. Hornstra G: Essential fatty acids, pregnancy, and pregnancy complications: a roundtable discussion. In Sinclair A, Gibson R (eds): “Essential Fatty Acids and Eicosanoids.” Champaign: American Oil Chemists’ Society, pp 177-182, 1992.
166. Neuringer M, Connor WE, Lin DS, Barstad L, Luck S: Biochemical and functional effects of prenatal and postnatal omega-6 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA 83:4021-4025, 1986.